Full List of Protein(s) Regulating This Metabolite |
Amino acid/auxin permease (AAAP) |
Sodium-coupled neutral amino acid transporter 9 (SLC38A9) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Truncation of SLC38A9 |
Induced Change |
Tyrosine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that truncation of SLC38A9 leads to the increase of tyrosine levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Overexpression of SLC38A9 |
Induced Change |
Tyrosine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that overexpression of SLC38A9 leads to the decrease of tyrosine levels compared with control group. |
Solute carrier family 38 member 2 (SLC38A2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Knockdown (siRNA) of SLC38A2 |
Induced Change |
Tyrosine concentration: increase (FC = 1.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockdown of SLC38A2 leads to the increase of tyrosine levels compared with control group. |
Solute carrier family 38 member 3 (SLC38A3) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Knockout of Slc38a3 |
Induced Change |
Tyrosine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of Slc38a3 leads to the decrease of tyrosine levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Knockout of SLC38A3 |
Induced Change |
Tyrosine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that knockout of SLC38A3 leads to the decrease of tyrosine levels compared with control group. |
Amino acid/polyamine transporter (AAPT) |
Integral membrane E16 (SLC7A5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Overexperisson of SLC7A5 |
Induced Change |
Tyrosine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that co-overexperisson of SLC7A5 and SLC7A8 leads to the decrease of tyrosine levels compared with control group. |
L-type amino acid transporter 2 (LAT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Overexperisson of SLC7A8 |
Induced Change |
Tyrosine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that co-overexperisson of SLC7A5 and SLC7A8 leads to the decrease of tyrosine levels compared with control group. |
GPCR secretin (GPCR-2) |
Glucagon receptor (GCGR) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Antagonist (GRA1) of GCGR |
Induced Change |
Tyrosine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hyperglycemic hyperosmolar syndrome [ICD-11: 5A20]
|
Details |
It is reported that antagonist of GCGR leads to the increase of tyrosine levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Knockout of Gcgr |
Induced Change |
Tyrosine concentration: increase (FC = 1.7) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Type 2 diabetes mellitus [ICD-11: 5A11]
|
Details |
It is reported that knockout of GCGR leads to the increase of tyrosine levels compared with control group. |
Hydrolases (EC 3) |
GTPase KRas (KRAS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Overexpression of KRAS |
Induced Change |
Tyrosine concentration: decrease (FC = 0.92) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Lung cancer [ICD-11: 2C25]
|
Details |
It is reported that overexpression of KRAS leads to the decrease of tyrosine levels compared with control group. |
Leukotriene-C4 hydrolase (GGT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Knockdown (siRNA) of GGT1 |
Induced Change |
Tyrosine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Renal cell carcinoma [ICD-11: 2C90]
|
Details |
It is reported that knockdown of GGT1 leads to the increase of tyrosine levels compared with control group. |
Sulfatase sulf-1 (SULF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Knockdown (shRNA) of SULF1 |
Induced Change |
Tyrosine concentration: decrease (FC = 0.47 / 0.48) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Ovarian cancer [ICD-11: 2C73]
|
Details |
It is reported that knockdown of SULF1 leads to the decrease of tyrosine levels compared with control group. |
Monocarboxylate porter (MNP) |
Monocarboxylate transporter 10 (SLC16A10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[11] |
Introduced Variation |
Overexpression of SLC16A10 |
Induced Change |
Tyrosine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that overexpression of SLC16A10 leads to the increase of tyrosine levels compared with control group. |
Pore-forming PNC peptide (PNC) |
Cellular tumor antigen p53 (TP53) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[12] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Tyrosine concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of tyrosine levels compared with control group. |
Transcription factor (TF) |
Forkhead box protein O1 (FOXO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[13] |
Introduced Variation |
Overexpression of Foxo1 |
Induced Change |
Tyrosine concentration: decrease (FC = 0.50) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that overexpression of Foxo1 leads to the decrease of tyrosine levels compared with control group. |
Myc proto-oncogene protein (MYC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[14] |
Introduced Variation |
Knockdown (siRNA) of MYC |
Induced Change |
Tyrosine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colorectal cancer [ICD-11: 2B91]
|
Details |
It is reported that knockdown of MYC leads to the decrease of tyrosine levels compared with control group. |
Zinc finger protein (ZIN) |
Protein snail homolog 1 (SNAI1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[15] |
Introduced Variation |
Knockdown (shRNA) of SNAI1 |
Induced Change |
Tyrosine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Breast cancer [ICD-11: 2C60]
|
Details |
It is reported that knockdown of Snai1 leads to the increase of tyrosine levels compared with control group. |
|
|
|
|
|
|
|